Corporate ActionJun 18, 2026, 04:37 PM
Sonoma Pharma Increases At-Market Offering to $3.64M
AI Summary
Sonoma Pharmaceuticals, Inc. announced an increase in its At Market Issuance Sales Agreement with Ladenburg Thalmann & Co. Inc., raising the aggregate offering price for common stock sales to $3,641,703. This includes $1,495,830 of common stock previously registered but not yet sold. Since September 26, 2025, the company has sold 173,073 shares for an aggregate purchase price of $574,633 under the agreement.
Key Highlights
- Aggregate offering price for common stock sales increased to $3,641,703.
- Includes $1,495,830 of common stock previously registered but unsold.
- From September 26, 2025, to June 18, 2026, 173,073 shares were sold.
- Aggregate purchase price from shares sold was $574,633.
- Original registered sale amount was up to $2,070,463.
Price Impact
More from SNOA
More in Corporate Action